Development of new methodologies for entry to targets of therapeutic interest

Full text not archived in this repository.

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Osborn, H.M.I. orcid id iconORCID: https://orcid.org/0000-0002-0683-0457 (2005) Development of new methodologies for entry to targets of therapeutic interest. Synlett (17). pp. 2571-2586. ISSN 0936-5214 doi: 10.1055/s-2005-917076

Abstract/Summary

This Account provides an overview of strategies that have been reported from our laboratories for the synthesis of targets of therapeutic interest, namely carbohydrates, and prodrugs for the treatment of melanoma. These programmes have involved the development of new synthetic methodologies including the regio- and stereoselective synthesis of specific carbohydrate isomers, and new protecting group methodologies. This review provides an insight into the progress of these research themes, and suggests some applications for the targets that are currently being explored.

Altmetric Badge

Item Type Article
URI https://reading-clone.eprints-hosting.org/id/eprint/13670
Identification Number/DOI 10.1055/s-2005-917076
Refereed Yes
Divisions Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy
Uncontrolled Keywords carbohydrates, prodrugs, regioselective, stereoselective, melanoma, LIPASE-CATALYZED ACYLATION, DIRECT CHEMICAL-SYNTHESIS, ALPHA-LINKED, GLCNAC, ONE-POT SYNTHESIS, ANOMERIC SUBSTITUENTS, MALIGNANT-MELANOMA, GLYCOSIDASE INHIBITORS, ESCHERICHIA-COLI, REGIOSELECTIVE, C-3-O-ACYLATION, PROTECTING GROUPS
Download/View statistics View download statistics for this item

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar